Tempsens Instruments IPO Day 3 Final Subscription Status: 184.16x Subscribed; GMP at ₹310
Tempsens Instruments (India) Limited’s IPO closed with an overall subscription of 184.16 times on 24 August 2026. The Tempsens Instruments IPO Day 3 Final Subscription Status shows Non-Institutional Investors (NIIs) leading at 314.41 times, closely followed by Qualified Institutional Buyers (QIBs) at 302.88 times. Retail demand reached 60.89 times. The Grey Market Premium (GMP) was around ₹310 after bidding closed.
| Metric | Final update |
| Bidding day | Day 3 Final |
| Data status | Final after bidding closed on 24 August 2026 |
| Overall subscription | 184.16x |
| QIB subscription | 302.88x |
| NII subscription | 314.41x |
| Retail subscription | 60.89x |
| Employee subscription | 124.75x |
| Current GMP | ₹310 |
| GMP percentage | 103.3% |
| Indicative price | ₹610 |
| Closing date | 24 August 2026 |
Tempsens Instruments IPO Day 3 Final Subscription Status
Based on final post-close exchange data, investors bid for about 279.58 crore shares against roughly 1.52 crore shares offered to the public, taking the overall subscription to 184.16 times.
| Investor category | Final subscription |
| Qualified Institutional Buyers (QIBs), ex-anchor | 302.88x |
| Non-Institutional Investors (NIIs) | 314.41x |
| Large NIIs | 331.34x |
| Small NIIs | 280.56x |
| Retail Individual Investors | 60.89x |
| Employees | 124.75x |
| Overall | 184.16x |
Demand was broad-based by the close. NIIs recorded the highest major-category subscription at 314.41 times, but QIB demand finished close behind at 302.88 times. Retail and employee portions were also subscribed several dozen times.
These multiples reflect the quantity of shares bid for relative to shares reserved in each category. They do not indicate the number of unique applicants, and category allocation affects how quickly individual subscription ratios can rise.
Final Day-wise Subscription Trend
The biggest change occurred on the closing day, when institutional bidding accelerated sharply.
| Bidding stage | Overall subscription | Leading category |
| Day 1 close | 5.95x | NII, 12.51x |
| Day 2 close | 21.69x | NII, 52.98x |
| Day 3 Final | 184.16x | NII, 314.41x |
Overall demand rose from 5.95 times on Day 1 to 21.69 times at the Day 2 close before reaching 184.16 times in the final book.
The most significant final-day shift came from QIBs. Their subscription increased from 3.31 times on Day 2 to 302.88 times at the close. NII demand also rose from 52.98 times to 314.41 times, while retail subscription climbed from 18.73 times to 60.89 times.
This means the final demand was much broader than the opening-day book, which had been led mainly by NIIs and retail investors.
Tempsens Instruments IPO GMP Today and Estimated Listing Price
Tempsens Instruments IPO GMP was around ₹310 as of early evening (5:00 p.m. to 6:30 p.m. IST) on 24 August 2026. Credible trackers showed quotes broadly ranging from about ₹300 to ₹329, while the median reading remained unchanged at ₹310 from 23 August.
| GMP observation | Premium | Movement |
| Current, 24 August 2026 | ₹310 | Unchanged |
| Previous available reading, 23 August 2026 | ₹310 | ₹0 |
| Current tracker range | ₹300 to ₹329 | Trackers differ |
At the upper price band of ₹300, a ₹310 GMP gives an indicative price of ₹610 per share.
Indicative price: ₹300 + ₹310 = ₹610
GMP percentage: ₹310 ÷ ₹300 × 100 = 103.3%
GMP is unofficial, unregulated, and can change quickly. It is not published by the Securities and Exchange Board of India (SEBI), National Stock Exchange of India (NSE), or BSE Limited (BSE). It does not guarantee the actual listing price or listing gains.
What Stands Out in Today’s Bidding
The clearest signal is the sharp closing-day increase in institutional demand. QIB subscription rose from 3.31 times after Day 2 to 302.88 times at the final close, while NIIs remained the most subscribed major category at 314.41 times.
The second signal is that the GMP stayed around ₹310 even as subscription accelerated substantially. That suggests the official bidding book and unofficial grey-market sentiment both remained elevated, although the GMP did not rise in line with the final-day jump in subscription.
The limitations are equally important. High subscription does not establish fair valuation or business quality, and GMP is not an exchange-traded price. Neither measure guarantees future returns.
IPO Details Retail Investors Need
| IPO detail | Information |
| Price band | ₹285 to ₹300 per share |
| Lot size | 50 shares |
| Minimum retail investment | ₹15,000 at the upper band |
| Issue size | ₹650 crore |
| Fresh issue | ₹95 crore |
| Offer for Sale (OFS) | ₹555 crore |
| Issue type | Mainboard book-built IPO |
| Closing date | 24 August 2026 |
| Expected listing date | 28 August 2026 |
| Exchange | BSE and NSE |
The Offer for Sale (OFS) accounts for ₹555 crore of the ₹650 crore issue, while the fresh issue contributes ₹95 crore.
Brief Company and Financial Context
Tempsens Instruments manufactures customised temperature-sensing solutions, electrical heating systems, and specialised cables for industrial customers in India and overseas. Revenue rose to ₹455.86 crore in FY26 from ₹382.47 crore in FY25, while profit after tax increased to ₹71.07 crore from ₹62.56 crore.
The company plans to use fresh proceeds primarily for repayment of certain borrowings, including about ₹55 crore earmarked for debt reduction, and around ₹18.13 crore for capital expenditure in electrical heating and specialised cable operations. One consideration is valuation, with the upper price band implying a post-issue earnings multiple of roughly 35 times FY26 earnings.
What Happens Next
With bidding closed, the basis of allotment is expected on 25 August 2026. Refund or fund-unblocking processes and credit of shares are scheduled for 27 August, subject to the final timetable. Tempsens Instruments shares are expected to list on the BSE and NSE on 28 August 2026.
Frequently Asked Questions (FAQs)
Q: How many times was the Tempsens Instruments IPO subscribed on Day 3 Final?
A: The Tempsens Instruments IPO closed with an overall subscription of 184.16 times on 24 August 2026. NIIs led at 314.41 times, QIBs were at 302.88 times, retail investors subscribed 60.89 times, and the employee portion reached 124.75 times.
Q: What is the Tempsens Instruments IPO GMP today?
A: The latest adopted GMP was around ₹310 on 24 August 2026, with credible tracker readings broadly ranging from ₹300 to ₹329. GMP is unofficial and can change before listing.
Q: What listing price does the current Tempsens Instruments IPO GMP indicate?
A: At the upper issue price of ₹300 and a GMP of ₹310, the indicative price is ₹610 per share. This represents an indicative GMP premium of about 103.3%, but it is not a guarantee of the actual listing price.
Q: Does 184.16x subscription guarantee a premium listing for Tempsens Instruments?
A: No. A high subscription multiple shows strong bidding demand relative to shares available, while GMP reflects unofficial grey-market sentiment. Neither guarantees a premium listing, fair valuation, business quality, or future investment returns.
Q: When is the expected Tempsens Instruments IPO allotment date?
A: The basis of allotment is expected to be finalised on 25 August 2026. Shares are scheduled to be credited on 27 August, with listing on the BSE and NSE expected on 28 August 2026, subject to the final exchange timetable.
Disclaimer
The stocks mentioned in this article are not recommendations. Please conduct your own research and due diligence before investing. Investment in securities market are subject to market risks, read all the related documents carefully before investing. Please read the Risk Disclosure documents carefully before investing in Equity Shares, Derivatives, Mutual fund, and/or other instruments traded on the Stock Exchanges. As investments are subject to market risks and price fluctuation risk, there is no assurance or guarantee that the investment objectives shall be achieved. Lemonn (Formerly known as NU Investors Technologies Pvt. Ltd) do not guarantee any assured returns on any investments. Past performance of securities/instruments is not indicative of their future performance.
